L-Citrulline in Peripheral Artery Disease (CIPER)
Beneficial Effects of the Amino-acid Food Supplement L-citrulline in Participants With Peripheral Artery Disease
Sponsor: Catharina Ziekenhuis Eindhoven
Listed as NCT02521220, this NA trial focuses on Peripheral Arterial Disease and remains completed. Sponsored by Catharina Ziekenhuis Eindhoven, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Jan 2019 — Oct 2019 [monthly]
Recruiting NA
-
Sep 2018 — Jan 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Catharina Ziekenhuis Eindhoven
- Clinical Trial Center Maastricht B.V.
- Hannover Medical School
- Maastricht University
For direct contact, visit the study record on ClinicalTrials.gov .